PHS
PFM Health Sciences Portfolio holdings
AUM
$1.15B
This Quarter Return
-3.88%
1 Year Return
+21.39%
3 Year Return
+130.75%
5 Year Return
+265.32%
10 Year Return
+1,236.5%
AUM
$1.31B
AUM Growth
+$1.31B
(-25%)
Cap. Flow
-$296M
Cap. Flow
% of AUM
-22.54%
Top 10 Holdings %
Top 10 Hldgs %
50.96%
Holding
96
New
18
Increased
9
Reduced
25
Closed
19
Top Buys
| 1 |
DexCom
DXCM
|
$25.6M |
| 2 |
Neurocrine Biosciences
NBIX
|
$22.8M |
| 3 |
iShares Core S&P Mid-Cap ETF
IJH
|
$21.7M |
| 4 |
Invesco S&P 500 Equal Weight ETF
RSP
|
$18.9M |
| 5 |
United Therapeutics
UTHR
|
$18.5M |
Top Sells
| 1 |
Cytokinetics
CYTK
|
$92.8M |
| 2 |
Merck
MRK
|
$61.6M |
| 3 |
Acadia Healthcare
ACHC
|
$43.5M |
| 4 |
Elevance Health
ELV
|
$29.3M |
| 5 |
Amgen
AMGN
|
$29.1M |
Sector Composition
| 1 | Healthcare | 92.49% |
